CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
To assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single
and multiple ascending oral doses of CKD-504 compared to placebo in healthy Korean and
Caucasian adult subjects